Paul Miller

Senior Director, Regulatory Technology, Operations & Filing Excellence at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Paul Miller's Colleagues at Alnylam Pharmaceuticals
Megha Katti

Associate Director, Market Insights

Contact Megha Katti

Kelly Dunn

Associate Scientist II, Bioanalytical Sciences

Contact Kelly Dunn

Scott Bishop

Senior Manager of Benefits for the Americas

Contact Scott Bishop

David Sinnott

Manager Quality Assurance

Contact David Sinnott

Eric Dahlgren

Associate Director, MTS

Contact Eric Dahlgren

Daniel Harris

Senior Manager, Clinical Operations

Contact Daniel Harris

View All Paul Miller's Colleagues
Paul Miller's Contact Details
HQ
(617) 551-8200
Location
Greater Boston Area
Company
Alnylam Pharmaceuticals
Paul Miller's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Paul Miller
Paul Miller currently works for Alnylam Pharmaceuticals.
Paul Miller's role at Alnylam Pharmaceuticals is Senior Director, Regulatory Technology, Operations & Filing Excellence.
Paul Miller's email address is ***@alnylam.com. To view Paul Miller's full email address, please signup to ConnectPlex.
Paul Miller works in the SaaS industry.
Paul Miller's colleagues at Alnylam Pharmaceuticals are Megha Katti, Nikki Ramos, Kelly Dunn, Scott Bishop, David Sinnott, Eric Dahlgren, Daniel Harris and others.
Paul Miller's phone number is (617) 551-8200
See more information about Paul Miller